In a groundbreaking move aiming to reshape the process of diagnosing colorectal cancer, the Community Diagnostic Centre (CDC) in Telford has launched a £1 million research study known as TRIOMIC. This innovative study is designed to significantly shorten the anxiety-inducing waiting period for a
Recent advancements in synthetic biology have opened new avenues for addressing antimicrobial resistance (AMR), a pressing global health threat. Synthetic biology encompasses the design and engineering of new or modified living systems to combat drug-resistant bacteria effectively. This field
Amgen's obesity drug candidate, MariTide (maridebart cafraglutide, formerly AMG 133), has brought forward promising results in a Phase II clinical trial, sparking hope for a new and effective treatment for obesity. With its innovative design and impressive efficacy, MariTide is positioned as a
Triple-negative breast cancer (TNBC) is a particularly aggressive form of breast cancer, accounting for 15-20% of all breast cancer cases. Known for its poor prognosis and lack of effective treatment options, TNBC presents a significant challenge in oncology. However, recent advancements in spatial
The recent research focusing on the safety of anti-seizure medications during pregnancy provides new insights that are crucial for expectant mothers. The study, led by Stanford Medicine and published in JAMA Neurology, evaluates the long-term effects of lamotrigine and levetiracetam on children
Gastroesophageal reflux disease (GERD) is a common condition characterized by chronic symptoms such as heartburn resulting from the regurgitation of stomach contents. If left untreated, GERD can lead to Barrett’s esophagus, a condition where the lining of the lower esophagus changes, increasing the
